The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
With the cases rising in the United States, it is crucial that individuals get tested often to sure they don't sprea the virus to others. COVID tests are available nationwide and offered at no cost at health centeres and select pharmacies. The Families First Coronavirus Response Act ensures that the COVID-19 PCR test is free to anyone in the United States, including the uninsured. Contact your health care provider or the local public health department for more information. For information about where to get a COVID test, visit this link: COVID testing locations.
Considerations for who should get tested:
COVID-19 Symptoms:
What to do If you Test Positive for COVID-19:
Click this link for more information from the CDC about testing information and more about COVID-19.
You Might Also Enjoy...
The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Read about how we use magnetic resonance therapy (MeRT) as a customized use of Transcranial Magnetic Stimulation (TMS).
While TMS is an FDA approved treatment to relieve symptoms of treatment resistant depression, it can be used for many off-label purposes as well.
Historic events have unfolded in the past few year and studies have shown that there is a link between the current state of the news and individual's mental health.
The World Health Organization (WHO) released a scientific brief that stated that there was a dramatic 25% increase in the global prevalence of depression and anxiety during the first year of the COVID-19 pandemic.
Happy Brain Awareness Week! Read more about the effect of different brain chemical messengers and their effect on mental health and every day functioning.